April 29, 2014
Kathleen Campbell Receives Scholar Excellence Award from SIUC
CARBONDALE, Ill. -- Southern Illinois University Carbondale Chancellor Rita Cheng honored numerous faculty and staff at the Faculty and Staff Excellence Awards, held April 28 at SIU in Carbondale.
“These seven individuals are being recognized for the contributions and passion they bring to student success, teaching, research and service to the university and our communities,” Chancellor Rita Cheng said. “Each of our honorees inspires us.”
Among the 2014 Faculty and Staff Excellence Award recipients was Kathleen C.M. Campbell, Ph.D., professor and director of audiology research in the Division of Otolaryngology in the Department of Surgery. She received the Scholar Excellence Award. The Scholar Excellence Award “recognizes and promotes outstanding research and creative endeavors,” and is given only to those “who have made outstanding contributions to their discipline” and who are “widely recognized for their achievements by other scholars in the field.”
Campbell is “undoubtedly one of the most meticulous, dedicated and prolific scholars in her field,” wrote Dr. Michael W. Neumeister, professor and chair of the surgery department. Campbell, who earned the SIU’s 2012 Inventor of the Year Award, is the first person in SIU history to move a drug she has patented at SIU into FDA-approved Phase 3 clinical trials, Neumeister wrote. She is principal investigator for a five-year project involving the final stages of research for an SIU School of Medicine patented drug aimed at preventing noise-induced hearing loss. In September 2013, the medical school announced a $2.5 million grant from the U.S. Department of Defense to support a Phase 3 clinical trial to determine if D-methionine can prevent noise-induced hearing loss in soldiers. Campbell is the inventor of the D-met drug.
Campbell has five U.S. patents covering four areas of invention and $4.2 million in active research funding. Her research has generated more than $8.2 million in national, international and patent income for the School of Medicine, according to Neumeister. “Her work will have a significant impact on the quality of life for many patients around the world who have been exposed to high noise levels, such as troops in the military, and may improve the quality of life for patients receiving chemotherapy or radiation therapy for cancer or receiving intravenous antibiotics for moderate to severe infections,” he wrote.
More than 40 students have also been involved with Campbell and her research activities, with several winning research awards for their work in her laboratory, Neumeister wrotes. In 2011, Alexander Claussen, a then-third year medical student, was the first student in medical school history to earn a one-year fully paid fellowship for translational and clinical research training program at the National Institutes of Health.
Martin D. Slade and Carrie A. Redlich of the Yale School of Medicine wrote that Campbell, an internationally renowned scholar, “has been, and continues to be, a pioneer in the quest to prevent hearing loss, a condition that affects almost 30 million Americans alone.” Campbell joined the School of Medicine faculty in 1989. She has served as principal investigator for more than 60 state and federal research grants focused primarily on ototoxicity and otoprotective agents. She is the author of “Essential Audiology for Physicians” and the author-editor of “Pharmacology and Ototoxicity for Audiologists,” a required text in most audiology doctoral programs.
Campbell received the permanent title of Distinguished Scholar, a certificate, $2,500 award and $1,000 other-than-salaries award.
Campbell earned her bachelor’s degree in communication/education from South Dakota State University (1973); a master’s degree in clinical audiology from the University of South Dakota (1977), and a doctorate in audiology/hearing science from the University of Iowa (1989).